Filtered By:
Source: American Heart Journal
Condition: Heart Failure
Drug: Byetta
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Baseline Characteristics of Patients Enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Conclusions EXSCEL is one of the largest global GLP-1RA trials, evaluating the safety and efficacy of EQW with a broad patient population that may extend generalizability compared to prior GLP-1RA trials (ClinicalTrials.gov number, NCT01144338).
Source: American Heart Journal - February 12, 2017 Category: Cardiology Source Type: research
